Crohn’s disease is a long-term condition that affects the digestive system. It is part of a group of illnesses known as inflammatory bowel diseases. People with Crohn’s disease often experience ...

Equillium, Inc. (NASDAQ:EQ) is one of the 10 Best High-Risk Penny Stocks to Buy Right Now. On March 13, Roth Capital analyst Adam Walsh initiated coverage of Equillium, Inc.

Abivax has appointed Michael Nesrallah as its chief commercial officer, putting one of the people who turned Takeda’s Entyvio into a blockbuster in charge of preparations for its own | Abivax has ...

Abivax (ABVX) stock dips after the company's 2025 results, as CEO signals that the biotech is not rushing to seek deals ahead of a major trial readout. Read more here.

The first asset will be a vedolizumab biosimilar to Entyvio used to treat adult patients with Crohn’s disease, ulcerative colitis or pouchitis.

Explore the latest advancements in treating ulcerative colitis using machine learning to discover new antimicrobial peptides.

Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.

Abivax Announces Full Year 2025 Financial Results and Provides Business UpdatesABTECT Phase 3 Data Safety Monitoring Board (DSMB) meeting on ...

Higher combined consumption of fruits, vegetables, legumes, and potatoes may reduce the risk for Crohn disease (CD), ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal ...

Advanced therapies are not linked to increased risk for serious or opportunistic infections, cancer, operations, or mortality among those with HIV and IBD.

Abivax and Nektar Therapeutics are clinical-stage biotech companies that would make attractive buyout targets.